Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$10,191,142
+$449,121 QoQ
Shares Held
28,143
+1.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#544
of 3,139 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GHP Investment Advisors, Inc. holds $46,475,498 across 14 Drug Manufacturers - General names. AMGN ranks #3 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
118,345 | $15,207,332 | |
| 2 | JNJ |
Johnson & Johnson
|
58,033 | $14,738,640 | |
| 3 | AMGN |
Amgen Inc
This page
|
28,143 | $10,191,142 | |
| 4 | LLY |
ELI LILLY & Co
|
1,816 | $2,178,165 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,971 | $1,638,755 | |
| 6 | ABBV |
AbbVie Inc.
|
5,799 | $1,459,260 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,952 | $342,954 | |
| 8 | NVO |
Novo Nordisk A S
|
4,826 | $231,358 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,191,142 | 28,143 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $9,742,021 | 27,688 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $8,789,582 | 26,854 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $7,586,100 | 26,882 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $7,676,878 | 27,495 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $8,519,022 | 27,344 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $6,903,310 | 26,486 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $8,027,539 | 24,914 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,470,367 | 23,909 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,305,933 | 22,179 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $6,151,819 | 21,359 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $5,549,356 | 20,648 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $4,467,930 | 20,124 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,447,233 | 18,396 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $4,582,017 | 17,446 | Shares | Sole | 2023-02-16 | |
| 2022-06-30 | $3,818,593 | 15,695 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,494,540 | 14,451 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $2,450,598 | 10,893 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,539,891 | 11,944 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,709,281 | 11,115 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,231,046 | 12,986 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,716,044 | 11,813 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,578,453 | 10,145 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,926,268 | 8,167 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,758,277 | 8,673 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||